Literature DB >> 18413636

Successful treatment of fulminant Clostridium difficile infection with fecal bacteriotherapy.

David M You, M Alaric Franzos, Robert P Holman.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18413636     DOI： 10.7326/0003-4819-148-8-200804150-00024

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  31 in total

Review 1.  Recurrent Clostridium difficile infection: From colonization to cure.

Authors:  Kelsey Shields; Roger V Araujo-Castillo; Thimmaiah G Theethira; Carolyn D Alonso; Ciaran P Kelly
Journal:  Anaerobe       Date:  2015-04-27       Impact factor: 3.331

Review 2.  Treatment of refractory and recurrent Clostridium difficile infection.

Authors:  Christina M Surawicz; Jacob Alexander
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-04-19       Impact factor: 46.802

Review 3.  Unravelling the effects of the environment and host genotype on the gut microbiome.

Authors:  Aymé Spor; Omry Koren; Ruth Ley
Journal:  Nat Rev Microbiol       Date:  2011-04       Impact factor: 60.633

4.  Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach.

Authors:  Monika Fischer; Brian Sipe; Yao-Wen Cheng; Emmalee Phelps; Nicholas Rogers; Sashidhar Sagi; Matthew Bohm; Huiping Xu; Zain Kassam
Journal:  Gut Microbes       Date:  2016-12-21

5.  Intestinal microbiota and the efficacy of fecal microbiota transplantation in gastrointestinal disease.

Authors:  Olga C Aroniadis; Lawrence J Brandt
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-04

Review 6.  Fecal microbiota transplantation and emerging applications.

Authors:  Thomas J Borody; Alexander Khoruts
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-12-20       Impact factor: 46.802

7.  Fecal microbiota transplantation in relapsing Clostridium difficile infection.

Authors:  Faith Rohlke; Neil Stollman
Journal:  Therap Adv Gastroenterol       Date:  2012-11       Impact factor: 4.409

8.  Elevated fecal calprotectin associates with adverse outcomes from Clostridium difficile infection in older adults.

Authors:  Krishna Rao; Kavitha Santhosh; Jill A Mogle; Peter D R Higgins; Vincent B Young
Journal:  Infect Dis (Lond)       Date:  2016-05-20

Review 9.  Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.

Authors:  Krishna Rao; Peter D R Higgins
Journal:  Inflamm Bowel Dis       Date:  2016-07       Impact factor: 5.325

Review 10.  Fecal microbiota transplantation for management of Clostridium difficile infection.

Authors:  Chetana Vaishnavi
Journal:  Indian J Gastroenterol       Date:  2014-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.